Pharming Group's market cap is currently $1.05B. The company's EPS TTM is $0.06; its P/E ratio is ―; Pharming Group is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
